Palasis Maria Insider Trades

Insider Trading History

Track insider trading activity for Palasis Maria. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Lyra Therapeutics
Lyra Therapeutics LYRA
Principal Executive Officer
Holding Value $547k 1,094,733 shares
Last Trade
Apr 01, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$880 2,000 shares
$0.44
$0.50
Lyra Therapeutics
Lyra Therapeutics LYRA
President & CEO
Holding Value $548k 1,096,733 shares
Last Trade
Jan 06, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$5.72k 1,702 shares
$3.36
$0.50
Lyra Therapeutics
Lyra Therapeutics LYRA
President & CEO
Holding Value $3.67k 7,333 shares
Last Trade
Oct 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$24.1k 3,667 shares
$6.57
$0.50
Lyra Therapeutics
Lyra Therapeutics LYRA
President & CEO
Holding Value $549k 1,098,435 shares
Last Trade
Jul 10, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$13.9k 1,565 shares
$8.91
$0.50
Lyra Therapeutics
Lyra Therapeutics LYRA
President & CEO
Holding Value $550k 1,100,000 shares
Last Trade
Jan 08, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$8.03M 800,000 shares
$10.04
$0.50
Lyra Therapeutics
Lyra Therapeutics LYRA
President & CEO
Holding Value $91.7k 183,333 shares
Last Trade
Dec 09, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.93M 183,333 shares
$10.55
$0.50
Lyra Therapeutics
Lyra Therapeutics LYRA
President & CEO
Holding Value $150k 300,000 shares
Last Trade
Oct 16, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.6M 300,000 shares
$12.01
$0.50
Lyra Therapeutics
Lyra Therapeutics LYRA
President & CEO
Holding Value $250k 500,000 shares
Last Trade
Mar 18, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$144M 500,000 shares
$288.50
$0.50
Lyra Therapeutics
Lyra Therapeutics LYRA
President & CEO
Holding Value $75k 150,000 shares
Last Trade
Jun 15, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$22.4M 150,000 shares
$149.50
$0.50
Lyra Therapeutics
Lyra Therapeutics LYRA
President & CEO
Holding Value $75k 150,000 shares
Last Trade
Jun 15, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$22.4M 150,000 shares
$149.50
$0.50
Lyra Therapeutics
Lyra Therapeutics LYRA
President & CEO
Holding Value $125k 250,000 shares
Last Trade
Jan 31, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$35.6M 250,000 shares
$142.50
$0.50
Lyra Therapeutics
Lyra Therapeutics LYRA
President & CEO
Holding Value $87.5k 175,000 shares
Last Trade
Feb 16, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$36.8M 175,000 shares
$210.50
$0.50
Lyra Therapeutics
Lyra Therapeutics LYRA
President & CEO
Holding Value $63.7k 127,400 shares
Last Trade
Feb 12, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$30.4M 127,400 shares
$239.00
$0.50
Lyra Therapeutics
Lyra Therapeutics LYRA
President & CEO
Holding Value $60k 120,000 shares
Last Trade
Feb 08, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$63.8M 120,000 shares
$531.50
$0.50
Lyra Therapeutics
Lyra Therapeutics LYRA
President & CEO
Holding Value $163k 326,303 shares
Last Trade
Apr 30, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.50
Lyra Therapeutics
Lyra Therapeutics LYRA
President & CEO
Holding Value $0 0 shares
Last Trade
Apr 30, 2020 Sale
No data
No data
$0.50

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up